Find stats on top websites

Business and Product Insights

Product Portfolio

Non-Invasive Medical Diagnostics Research

Know Labs Internal Clinical Studies

Bio-RFID Non-Invasive Diagnostic Technology

Know Labs, Inc. Key Value Propositions

Know Labs' key value proposition lies in its proprietary non-invasive RFDS technology, backed by an extensive IP portfolio of over 330 patents. This is coupled with a flexible licensing program and a comprehensive commercialization toolkit, enabling partners to rapidly develop and integrate advanced sensing solutions with reduced R&D risks.

Non-Invasive RFDS Technology
Extensive IP Portfolio
Flexible Licensing Program
Comprehensive Commercialization Toolkit

Know Labs, Inc. Brand Positioning

Know Labs positions itself as the leading licensor of non-invasive RFDS technology, empowering enterprises to integrate advanced sensing capabilities. They focus on IP leadership, collaborative innovation, and rapid commercialization across healthcare, automotive, and industrial sectors.

Top Competitors

1

Dexcom

2

Abbott Diabetes Care

3

Rockley Photonics

Customer Sentiments

Customer sentiment appears positive, as they are actively seeking advanced, mature technology platforms with strong IP and comprehensive support to de-risk R&D and accelerate time-to-market. The emphasis on collaboration and customizability suggests a high value placed on Know Labs' offerings.

Actionable Insights

Develop targeted marketing campaigns showcasing successful multi-industry applications of RFDS technology to attract a broader range of enterprise partners.

Products and Features

Non-Invasive Medical Diagnostics Research - Product Description

Know Labs is actively engaged in the research and development of non-invasive medical diagnostic devices, with a specific focus on achieving FDA submission for clearance. The company is committed to building a strong foundation of scientific evidence through continuous, ongoing clinical trials. This indicates a focus on rigorous validation and adherence to regulatory standards for their innovative diagnostic technologies.

Pros

  • The product is on the path to FDA submission, indicating a serious commitment to regulatory approval and market readiness
  • Ongoing clinical trials are continuously adding to a growing body of scientific evidence, bolstering the credibility and effectiveness of their non-invasive medical diagnostics
  • The non-invasive nature of the diagnostics suggests improved patient comfort and potentially broader applicability compared to traditional invasive methods.

Cons

  • The product is still in the R&D phase and has not yet received FDA clearance, meaning it is not commercially available
  • The success and timeline for FDA approval are uncertain and subject to various regulatory hurdles and trial outcomes
  • Specific details about the diagnostic technology itself (e.g., what it diagnoses, its accuracy metrics) are not provided, making it difficult to fully assess its potential limitations.

Alternatives

  • Current alternatives for medical diagnostics often involve traditional invasive methods like blood draws or biopsies
  • Competitors developing non-invasive diagnostic technologies would include other biotech or med-tech companies in the R&D phase
  • Established medical device companies may also be investing in or acquiring non-invasive diagnostic innovations.

Company Updates

Latest Events at Know Labs, Inc.

News | Know Labs | Non-invasive Medical Diagnostic Technology

Learn more about the Know Labs story. Read the latest press releases and coverage from the media.

View source

Press Releases :: Know Labs, Inc. (KNW)

News & Events · Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy · Know Labs Sensor Non-Invasively Identifies pH ...

View source

Home | Know Labs | Non-invasive Medical Diagnostic Technology

Know Labs is transforming non-invasive medical diagnostics. Its proprietary radiofrequency (RF) sensor measures glucose levels using dielectric spectroscopy ...

View source

Know Labs - $KNW (@TheKnowLabs) / X

Meet the Company Building the First-Ever Noninvasive Blood Glucose Monitoring Device - MedCity News ... Learn more here: https://knowlabs.co/post/know-labs- ...

View source

Transform Your Ideas into Action in Minutes with WaxWing

Sign up now and unleash the power of AI for your business growth